Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nichols

Showing results (611-620 of 624) with videos related to

Pageof 63
Sort By:
Neurosurgery|July 21, 2010
External carotid artery stenting to treat patients with symptomatic ipsilateral internal carotid artery occlusion: a multicenter case seriesDavid S Xu, Todd A Abruzzo, Felipe C Albuquerque, et al.
Journal of Structural and Functional Genomics|January 9, 2009
The Center for Eukaryotic Structural GenomicsJohn L Markley, David J Aceti, Craig A Bingman, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2019
Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus LuteumFrauke von Versen-Höynck, Amelia M Schaub, Yueh-Yun Chi, et al.
Biochemistry|September 24, 1999
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosanW H Ward, G A Holdgate, S Rowsell, et al.
Retina (Philadelphia, Pa.)|January 12, 2018
FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment TrialAkosua A Nti, Leona W Serrano, Harpal S Sandhu, et al.
Genome Biology|January 14, 2017
Identifying aggressive prostate cancer foci using a DNA methylation classifierKamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, et al.
Autophagy|July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaDan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Environmental Toxicology and Chemistry|October 29, 2021
The Eco-Exposome Concept: Supporting an Integrated Assessment of Mixtures of Environmental ChemicalsStefan Scholz, John W Nichols, Beate I Escher, et al.
Pageof 63

Showing results (611-620 of 624) with videos related to

Sort By:
Pageof 63
Neurosurgery|July 21, 2010
External carotid artery stenting to treat patients with symptomatic ipsilateral internal carotid artery occlusion: a multicenter case seriesDavid S Xu, Todd A Abruzzo, Felipe C Albuquerque, et al.
Journal of Structural and Functional Genomics|January 9, 2009
The Center for Eukaryotic Structural GenomicsJohn L Markley, David J Aceti, Craig A Bingman, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2019
Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus LuteumFrauke von Versen-Höynck, Amelia M Schaub, Yueh-Yun Chi, et al.
Biochemistry|September 24, 1999
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosanW H Ward, G A Holdgate, S Rowsell, et al.
Retina (Philadelphia, Pa.)|January 12, 2018
FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment TrialAkosua A Nti, Leona W Serrano, Harpal S Sandhu, et al.
Genome Biology|January 14, 2017
Identifying aggressive prostate cancer foci using a DNA methylation classifierKamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, et al.
Autophagy|July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaDan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Environmental Toxicology and Chemistry|October 29, 2021
The Eco-Exposome Concept: Supporting an Integrated Assessment of Mixtures of Environmental ChemicalsStefan Scholz, John W Nichols, Beate I Escher, et al.
Pageof 63